Evidence map›Paper›PMID 33986676›Full record

ArticleFrontiers in pharmacology2021

Frutescone O from

Xiaobing Lin, Junhan Zhang, Decai Fan, Jiqin Hou, Hao Wang, Lin Zhu, Ruina Tian, Xiaofei An, Ming Yan

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. LC-MS/MS Chemical Profiling and HPLC/PDA Quantification ofPharmaceuticals (Basel, Switzerland) · 2026
    Article
  3. Article
  4. Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2024
    Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Xiaobing LinInstitute of Pharmaceutical Science, China Pharmaceutical University, Nanjing, China.
Junhan ZhangInstitute of Pharmaceutical Science, China Pharmaceutical University, Nanjing, China.
Decai FanInstitute of Pharmaceutical Science, China Pharmaceutical University, Nanjing, China.
Jiqin HouDepartment of Natural Medicinal Chemistry, China Pharmaceutical University, Nanjing, China.
Hao WangDepartment of Natural Medicinal Chemistry, China Pharmaceutical University, Nanjing, China.
Lin ZhuDepartment of Endocrinology, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China.
Ruina TianDepartment of Endocrinology, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China.
Xiaofei AnDepartment of Endocrinology, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China.
Ming YanInstitute of Pharmaceutical Science, China Pharmaceutical University, Nanjing, China.
China Pharmaceutical University · CNNanjing University of Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Frutescone O was isolated from the aerial parts of

Indexed as

Frutescone OMAPKsMyD88NF-κBTLR4 (toll-like receptor 4)

Identifiers

PMID33986676
PMCPMC8112673
OpenAlexW3158547252

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.